Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)1,592.00
  • Today's Change2.50 / 0.16%
  • Shares traded107.67k
  • 1 Year change-26.91%
  • Beta1.1277
Data delayed at least 15 minutes, as of Nov 08 2024 15:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue16,47414,5058,417
OPERATING EXPENSES
Cost of revenue total22600
Selling, general and admin. expenses, total3,2522,6381,266
Depreciation/amortization10010817
Unusual expense(income)038--
Other operating expenses, total------
Total operating expense11,1538,2385,464
Operating income5,3216,2672,953
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes5,6376,9453,918
Provision for income taxes1,2851,493961
Net income after taxes4,3525,4522,957
Minority interest------
Net income before extra. Items4,3525,4522,957
Total extraordinary items------
Net income4,3525,4522,957
Inc.avail. to common excl. extra. Items4,3525,4522,957
Inc.avail. to common incl. extra. Items4,3525,4522,957
EPS RECONCILIATION
Basic/primary weighted average shares656565
Basic/primary eps excl. extra items678345
Basic/primary eps incl. extra items678345
Dilution adjustment------
Diluted weighted average shares666666
Diluted eps excl. extra items668345
Diluted eps incl. extra items668345
COMMON STOCK DIVIDENDS
DPS - common stock primary issue----0
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental272113
SUPPLEMENTAL INCOME
Depreciation, supplemental272220166
Total special items038--
NORMALISED INCOME
Normalized income before taxes5,6376,9833,918
Effect of special items on income taxes08.17--
Income tax excluding impact of special items1,2851,501961
Normalized income after tax4,3525,4822,957
Normalized income avail. to common4,3525,4822,957
Basic normalized EPS678445
Diluted normalized EPS668345
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.